Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Digital Pathology Firm Proscia Raises $37M in Series C Round

Proscia
By Author Proscia | June 14, 2022

Proscia said in a statement that the funding will allow it to accelerate adoption of computational pathology, led by its artificial intelligence-based Concentriq platform. The company will use the money to scale its commercial operations by expanding its sales, marketing, and support teams, along with growing distribution partnerships.

Our website uses cookies. By using this site, you agree to its use of cookies.